newsfilter
← Latest News
GlobeNewswire·

Caladrius Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

BASKING RIDGE, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease,